These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 31728833

  • 21. MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells.
    Nishida N, Yamashita S, Mimori K, Sudo T, Tanaka F, Shibata K, Yamamoto H, Ishii H, Doki Y, Mori M.
    Ann Surg Oncol; 2012 Sep; 19(9):3065-71. PubMed ID: 22322955
    [Abstract] [Full Text] [Related]

  • 22. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer.
    Jin G, Liu Y, Zhang J, Bian Z, Yao S, Fei B, Zhou L, Yin Y, Huang Z.
    Cancer Chemother Pharmacol; 2019 Aug; 84(2):315-325. PubMed ID: 31089750
    [Abstract] [Full Text] [Related]

  • 23. Exosome-mediated delivery of miR-204-5p inhibits tumor growth and chemoresistance.
    Yao S, Yin Y, Jin G, Li D, Li M, Hu Y, Feng Y, Liu Y, Bian Z, Wang X, Mao Y, Zhang J, Wu Z, Huang Z.
    Cancer Med; 2020 Aug; 9(16):5989-5998. PubMed ID: 32618144
    [Abstract] [Full Text] [Related]

  • 24. MicroRNA-425-5p regulates chemoresistance in colorectal cancer cells via regulation of Programmed Cell Death 10.
    Zhang Y, Hu X, Miao X, Zhu K, Cui S, Meng Q, Sun J, Wang T.
    J Cell Mol Med; 2016 Feb; 20(2):360-9. PubMed ID: 26647742
    [Abstract] [Full Text] [Related]

  • 25. miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer.
    Wu YZ, Lin HY, Zhang Y, Chen WF.
    J Gene Med; 2020 Jul; 22(7):e3178. PubMed ID: 32092782
    [Abstract] [Full Text] [Related]

  • 26. Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway.
    Jiang L, Zhang Y, Guo L, Liu C, Wang P, Ren W.
    BMC Cancer; 2021 Dec 02; 21(1):1290. PubMed ID: 34856955
    [Abstract] [Full Text] [Related]

  • 27. MiR-744 mediates the Oxaliplatin chemoresistance in colorectal cancer through inhibiting BIN1.
    Zhou Y, He A, Zhang L, Yi G.
    Neoplasma; 2020 Mar 02; 67(2):296-303. PubMed ID: 31884801
    [Abstract] [Full Text] [Related]

  • 28. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy via transforming growth factor-β/Smad4 pathway.
    Sun C, Wang FJ, Zhang HG, Xu XZ, Jia RC, Yao L, Qiao PF.
    World J Gastroenterol; 2017 Mar 14; 23(10):1816-1827. PubMed ID: 28348487
    [Abstract] [Full Text] [Related]

  • 29. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL, Chen YL, Ge ZZ, Qu YY, Cao Y, Kang ZX.
    Cancer Biomark; 2019 Mar 14; 26(1):69-77. PubMed ID: 31306108
    [Abstract] [Full Text] [Related]

  • 30. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145.
    Gao R, Fang C, Xu J, Tan H, Li P, Ma L.
    Arch Biochem Biophys; 2019 Mar 15; 663():183-191. PubMed ID: 30639170
    [Abstract] [Full Text] [Related]

  • 31. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma.
    Yin J, Zeng A, Zhang Z, Shi Z, Yan W, You Y.
    EBioMedicine; 2019 Apr 15; 42():238-251. PubMed ID: 30917935
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of miR-19a partially reversed the resistance of colorectal cancer to oxaliplatin via PTEN/PI3K/AKT pathway.
    Zhang Y, Liu X, Zhang J, Xu Y, Shao J, Hu Y, Shu P, Cheng H.
    Aging (Albany NY); 2020 Mar 25; 12(7):5640-5650. PubMed ID: 32209726
    [Abstract] [Full Text] [Related]

  • 33. In vitro exosomal transfer of Nrf2 led to the oxaliplatin resistance in human colorectal cancer LS174T cells.
    Mostafazadeh M, Kahroba H, Haiaty S, TazeKand AP, Samadi N, Rahbarghazi R, Nouri M.
    Cell Biochem Funct; 2022 Jun 25; 40(4):391-402. PubMed ID: 35474580
    [Abstract] [Full Text] [Related]

  • 34. CAFs-secreted exosomal cricN4BP2L2 promoted colorectal cancer stemness and chemoresistance by interacting with EIF4A3.
    Qu Z, Yang KD, Luo BH, Zhang F.
    Exp Cell Res; 2022 Sep 15; 418(2):113266. PubMed ID: 35752345
    [Abstract] [Full Text] [Related]

  • 35. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C, Zhang L, Sun Y, Li X, Zhan L, Lou Y, Wang Y, Liu L, Zhang Y.
    Biomed Pharmacother; 2018 May 15; 101():945-952. PubMed ID: 29635904
    [Abstract] [Full Text] [Related]

  • 36. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
    Lv L, Li Q, Chen S, Zhang X, Tao X, Tang X, Wang S, Che G, Yu Y, He L.
    Exp Cell Res; 2019 Dec 01; 385(1):111597. PubMed ID: 31525340
    [Abstract] [Full Text] [Related]

  • 37. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
    Hu J, Cai G, Xu Y, Cai S.
    Curr Mol Med; 2016 Dec 01; 16(1):70-82. PubMed ID: 26695693
    [Abstract] [Full Text] [Related]

  • 38. Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells.
    Zhang Q, Liu RX, Chan KW, Hu J, Zhang J, Wei L, Tan H, Yang X, Liu H.
    J Exp Clin Cancer Res; 2019 Jul 19; 38(1):320. PubMed ID: 31324203
    [Abstract] [Full Text] [Related]

  • 39. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
    Ren J, Ding L, Zhang D, Shi G, Xu Q, Shen S, Wang Y, Wang T, Hou Y.
    Theranostics; 2018 Jul 19; 8(14):3932-3948. PubMed ID: 30083271
    [Abstract] [Full Text] [Related]

  • 40. miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma.
    Xu K, Chen G, Qiu Y, Yuan Z, Li H, Yuan X, Sun J, Xu J, Liang X, Yin P.
    Oncotarget; 2017 Mar 28; 8(13):21719-21732. PubMed ID: 28423513
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.